Phibro Animal Health Corporation (PAHC) Stock Analysis

Sector: HEALTHCARE - DRUG MANUFACTURERS - SPECIALTY & GENERIC

Exchange: NASDAQ

Key Metrics

• Price: $54.70
• Market Cap: $2.15B
• P/E Ratio: 22.69
• EPS: $2.34
• 52-Week High: $56.30
• 52-Week Low: $15.98

Market Sentiment

Phibro Animal Health Corporation currently has a Neutral sentiment score of 0.13.

About Phibro Animal Health Corporation

Phibro Animal Health Corporation (PAHC) is a prominent global leader in the development and supply of animal health and nutrition products, dedicated to enhancing the health and productivity of livestock worldwide. Based in Teaneck, New Jersey, the company utilizes its extensive expertise in veterinary pharmaceuticals and nutritional innovations to effectively address the evolving challenges faced by animal producers, particularly in the U.S. Phibro's commitment to rigorous research and devel...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Phibro Animal Health Corporation and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does PAHC pay dividends?

Phibro Animal Health Corporation (PAHC) does not currently pay a regular dividend.

What is PAHC's P/E ratio?

Phibro Animal Health Corporation has a price-to-earnings (P/E) ratio of 22.69.

What is PAHC's market cap?

Phibro Animal Health Corporation (PAHC) has a market capitalization of $2.15B with a current stock price of $54.70.